Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK

Khan, Niamat; Pantakani, D. V. Krishna; Binder, Lutz; Qasim, Muhammad; Asif, Abdul R.

doi:10.3389/fphys.2015.00381

ORIGINAL RESEARCH article

Front. Physiol. , 22 December 2015

Sec. Gastrointestinal Sciences

Volume 6 - 2015 | https://doi.org/10.3389/fphys.2015.00381

This article is part of the Research Topic Inositide signaling targets in gastrointestinal diseases View all 7 articles

Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK

Retracted

A retraction of this article was approved in:

Retraction: Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK
1. Read retraction

$\r\nNiamat Khan,$ Niamat Khan^1,2

D. V. Krishna Pantakani¹

Lutz Binder¹

Muhammad Qasim^1,3

Abdul R. Asif¹^*

¹Proteomics Group, Institute for Clinical Chemistry/UMG-Laboratories, University Medical Centre, Goettingen, Germany
²Department of Biotechnology and Genetic Engineering, Kohat University of Science and Technology, Kohat, Pakistan
³Department of Microbiology, Kohat University of Science and Technology, Kohat, Pakistan

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Khan N, Pantakani DVK, Binder L, Qasim M and Asif AR (2015) Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK. Front. Physiol. 6:381. doi: 10.3389/fphys.2015.00381

Received: 20 September 2015; Accepted: 24 November 2015;
Published: 22 December 2015; Retracted: 19 September 2017.

Edited by:

Alexis E. Traynor-Kaplan, ISM Therapeutics, USA

Reviewed by:

Georg Singer, Medical University of Graz, Austria
R. John MacLeod, Queen's University, Canada

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good